Metastatic Colorectal Cancers Completed Phase 1 Trials for Dasatinib (DB01254)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00920868XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + DasatinibTreatment